Skip to content

LivaNova LIVN Debt Repayments

Debt Repayments at other companies

Abbott logo
AbbottABT
$1.42B+41.5%
Haemonetics logo
HaemoneticsHAE
-$4.69M-400%
Medtronic logo
MedtronicMDT
$1.77B
ITG
Integer HoldingsITGR
$0-100%
ResMed logo
ResMedRMD
$5M0.0%
Stryker logo
StrykerSYK
$1B

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's debt repayments?
LivaNova (LIVN) reported debt repayments of $95.94M in Q1 2026.
How has LivaNova's debt repayments changed year-over-year?
LivaNova's debt repayments increased by 2092.9% year-over-year, from $4.38M to $95.94M.
What is the long-term trend for LivaNova's debt repayments?
Over 3 years (2022 to 2025), LivaNova's debt repayments has grown at a 7.9% compound annual growth rate (CAGR), from $223.54M to $280.93M.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.